Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 02, 2004 09:30 ET | Source: HepaLife Technologies, Inc.

HepaLife Technologies, Inc. -- Dr. Ayesha Mahmood Joins Research Team

VANCOUVER, British Columbia, Aug. 2, 2004 (PRIMEZONE) -- HepaLife Technologies, Inc. (OTCBB:HPLF), a development stage biotechnology company focused on the research, development and eventual...
July 06, 2004 09:30 ET | Source: HepaLife Technologies, Inc.

HepaLife Receives Approval for Trading on Frankfurt Stock Exchange

VANCOUVER, British Columbia, July 6, 2004 (PRIMEZONE) -- HepaLife Technologies, Inc. (OTCBB:HPLF), an early stage biotechnology company focused on developing the first of its kind artificial liver...
June 15, 2004 10:09 ET | Source: HepaLife Technologies, Inc.

HepaLife Announces Formation of Distinguished Scientific Advisory Board

VANCOUVER, British Columbia, June 15, 2004 (PRIMEZONE) -- HepaLife Technologies, Inc. (OTCBB:HPLF), a development stage biotechnology company focused on the research, development and eventual...
June 01, 2004 06:30 ET | Source: HepaLife Technologies, Inc.

HepaLife Announces Expansion and Extension of Cooperative Research Agreement

VANCOUVER, British Columbia, June 1, 2004 (PRIMEZONE) -- HepaLife Technologies, Inc. (OTCBB:HPLF), a development stage biotechnology company focused on the research, development and eventual...
May 14, 2004 14:28 ET | Source: HepaLife Technologies, Inc.

HepaLife Expands into Developing Technology for Hepatotoxicity, the Most Common Reason Cited for the Withdrawal of an Approved Drug, Pre-Clinical Drug Failures, and for Refusal of Drug Approval by the FDA

VANCOUVER, B.C., May 14, 2004 (PRIMEZONE) -- HepaLife Technologies, Inc. (OTCBB:HPLF), a development stage biotechnology company focused on technologies and products to treat various forms of liver...
April 14, 2004 14:37 ET | Source: HepaLife Technologies, Inc.

HepaLife Approved for Listing on Berlin Bremen Exchange

VANCOUVER, B.C., April 14, 2004 (PRIMEZONE) -- HepaLife Technologies, Inc. (OTCBB:HPLF) is pleased to announce that effective immediately the Company has been approved for dual listing on the Berlin...
January 07, 2004 10:00 ET | Source: HepaLife Technologies, Inc.

HepaLife Announces Results of First Phase Research

VANCOUVER, British Columbia, Jan. 7, 2004 (PRIMEZONE) -- HepaLife Technologies, Inc. (OTCBB:HPLF) is pleased to announce the initial results of its first phase of research towards the development of...
December 17, 2003 09:20 ET | Source: HepaLife Technologies, Inc.

HepaLife to Release Latest Research Results

VANCOUVER, British Columbia, Dec. 17, 2003 (PRIMEZONE) -- HepaLife Technologies, Inc. (OTCBB: HPLF) is pleased to announce that it will be releasing the results of recent scientific research on the...
November 20, 2003 14:35 ET | Source: HepaLife Technologies, Inc.

HepaLife appoints Mr. Jasvir S. Kheleh as Director

VANCOUVER, British Columbia, Nov. 20, 2003 (PRIMEZONE) -- HepaLife Technologies, Inc. (OTCBB:HPLF) is pleased to announce the appointment of Mr. Jasvir S. Kheleh as a Director, a position previously...
October 07, 2003 09:30 ET | Source: HepaLife Technologies, Inc.

Hepatitis Now More Prevalent Than AIDS; HepaLife Developing Artificial Liver in Response to Growing Base of Liver Disease Sufferers

VANCOUVER, British Columbia, Oct. 7, 2003 (PRIMEZONE) -- Accounting for an estimated 40% of all deaths due to chronic liver disease, hepatitis C is a deadly virus that enters the blood system and...

Next Page keyboard_arrow_right